[ORGANIZATION]
Pfizer Inc.
Featured in 23 tracked stories · first seen
Situations
Pfizer financial performance and market recovery
3 clusters · 12 sources · last updated
Latest: Pfizer raises 2026 revenue and earnings guidance
Pfizer has demonstrated signs of financial recovery, with its shares reaching a 52-week high. The stock has risen 20 percent year to date, maintaining a forward dividend yield of approximately 5.8 percent. Technical anal
Novo Nordisk raises 2026 outlook on Wegovy demand
116 clusters · 557 sources · last updated
Latest: Nestlé and Novo Nordisk report strong third-quarter results
Novo Nordisk is navigating market volatility and patent risks, specifically the potential for generic competition as U.S. patents for its primary active ingredients expire in 2032. While the company faces intense competi
Global vitamin and dietary supplements market trends
3 clusters · 6 sources · last updated
Latest: Dietary supplements market projected to reach $299.57 billion by 2031
The global vitamin supplements market is experiencing significant growth, with the total market valued at approximately USD 60 billion in 2025 and projected to expand at a compound annual growth rate of 7.5% through 2030
Also covered in
-
Pancreatitis markets projected to grow significantly through 2030
[HEALTH] · 2 sources ·
-
Neogen and Pfizer see significant market and institutional activity
[BUSINESS] · 5 sources ·
-
Arbutus Biopharma announces $230 million share repurchase plan
[BUSINESS] · 4 sources ·
-
Valneva and Pfizer Lyme vaccine candidate enters EMA review
[BUSINESS] · 5 sources ·
-
Pfizer's berobenatide weight‑loss drug draws market attention
[BUSINESS] · 3 sources ·
-
Pfizer oncology sales climb 9% after Seagen acquisition amid strong health‑sector outlook
[BUSINESS] · 2 sources ·
-
Pfizer’s Genetically Engineered Chymosin Dominates US Cheese Production
[BUSINESS] · 2 sources ·